Evidence map›Paper›PMID 33867871›Full record

ArticleMolecular imaging2021

Skye Hsin-Hsien Yeh, Ming Hsien Lin, I I Leo Garcia Flores, Uday Mukhopadhyay, Danial Young, Kazuma Ogawa, Jeong-Hwan Jeong, William Tong, Juri G Gelovani, Nobuyoshi Fukumitsu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 6 countries.

Skye Hsin-Hsien YehBrain Research Center, National Yang Ming Chaio Tung University, Taipei, Taiwan.
Ming Hsien LinDepartment of Nuclear Medicine, Camillian Saint Mary's Hospital Luodong, Yilan, Taiwan.
I I Leo Garcia FloresRadiomedix, Inc., Houston, USA.
Uday MukhopadhyayCyclotron Research Facility, Center for Advanced Biomedical Imaging, U.T.M.D. Anderson Cancer Center, Houston, USA.
Danial YoungCyclotron Research Facility, Center for Advanced Biomedical Imaging, U.T.M.D. Anderson Cancer Center, Houston, USA.
Kazuma OgawaInstitute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
Jeong-Hwan JeongDepartment of Nuclear Medicine, Chonbuk National University Medical School & Hospital, Republic of Korea.
William TongCyclotron Research Facility, Center for Advanced Biomedical Imaging, U.T.M.D. Anderson Cancer Center, Houston, USA.
Juri G GelovaniOncology, Neurosurgery, OBGYN, Biomedical Engineering, Wayne State University, Detroit, USA.ORCID 0000-0002-8413-6161
Nobuyoshi FukumitsuDepartment of Radiation Oncology, Kobe Proton Center, Kobe, Japan.ORCID 0000-0003-2417-8199
The University of Texas MD Anderson Cancer Center · USJeonbuk National University · KRKanazawa University · JPNational Yang Ming Chiao Tung University · TWRadioMedix (United States) · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combining standard drugs with low doses of histone deacetylase inhibitors (HDACIs) is a promising strategy to increase the efficacy of chemotherapy. The ability of well-tolerated doses of HDACIs that act as chemosensitizers for platinum-based chemotherapeutics has recently been proven in many types and stages of cancer

Indexed as

CarcinomaCarcinoma, Non-Small-Cell LungLung NeoplasmsCell Line, TumorCisplatinFluorodeoxyglucose F18HumansHydroxamic AcidsLungPositron Emission Tomography Computed TomographyVorinostatCisplatinFluorodeoxyglucose F18Hydroxamic AcidsVorinostat

Identifiers

PMID33867871
PMCPMC8032518
OpenAlexW3151024962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.